Clik here to view.
Avera Health Plans “Goes Live” in Record Time with RxAdvance, New Pharmacy...
SOUTHBOROUGH, Mass. Avera Health Plans’ new pharmacy benefit manager (PBM), RxAdvance, today announced record-time implementation of comprehensive, innovative PBM services for the insurer’s members....
View ArticleClik here to view.
European Commission Approves Label Variation for ADCETRIS® (Brentuximab...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the European Commission (EC) has approved a Type II variation for ADCETRIS® (brentuximab...
View ArticleClik here to view.
ViroMed Publishes Results from Critical Limb Ischemia (CLI) Phase II Clinical...
SEOUL, Korea ViroMed Co., Ltd. (KOSDAQ:084990) has announced the publication of the results from successfully completed phase II clinical study of VM202 for the treatment of critical limb ischemia...
View ArticleClik here to view.
Clik here to view.
Kyoto University and Panasonic Developed New Remote Sensing Technology for...
KYOTO & OSAKA, Japan Kyoto University and Panasonic Corporation today announced that they developed a new remote sensing technology for vital signs such as heart rate, heartbeat interval and...
View ArticleClik here to view.
エイトリキュアが日本でのAtriClipの承認を発表
米オハイオ州ウェストチェスター （ビジネスワイヤ） — 心房細動（Afib）治療と左心耳（LAA）管理における一流イノベーター企業のエイトリキュア（Nasdaq: ATRC）は本日、AtriClip™ StandardやAtriClip Pro™の各デバイスを含め、AtriClip™製品の承認を厚生労働省より取得したと発表しました。...
View ArticleClik here to view.
Kyoto University and Panasonic Developed New Remote Sensing Technology for...
KYOTO & OSAKA, Japan Kyoto University and Panasonic Corporation today announced that they developed a new remote sensing technology for vital signs such as heart rate, heartbeat interval and...
View ArticleClik here to view.
京都大学和松下公司开发毫米波雷达生命体征新遥感技术
日本京都和大阪 (美国商业资讯)–京都大学和松下公司今天宣布，他们开发了一项测量心率、心跳间隔等生命体征的新遥感技术。这项技术包括高灵敏扩频雷达和基于特征的心跳间隔估计算法，无需在身体上放置传感器即可测量心率和心跳间隔，并可实现与心电图仪同样的高精度。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Establishment of Nitto BioPharma, Inc.
OSAKA, Japan Japan’s leading diversified materials manufacturer Nitto Denko Corporation (TOKYO:6988)(ISIN:JP3684000007) established a new company, Nitto BioPharma, Inc., with a focus on...
View ArticleClik here to view.
欧盟核准ADCETRIS® (Brentuximab...
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社 (TSE:4502)今天宣布，欧盟(EC)已核准ADCETRIS® (brentuximab...
View ArticleAcelity L.P. Inc. Reports Fourth Quarter and Full Year Financial Results for...
SAN ANTONIO Acelity L.P. Inc.: Fourth Quarter Financial Highlights Revenue for the fourth quarter of 2015 of $483.8 million, grew 0.2% as reported on a GAAP basis from the prior-year period and grew...
View ArticleClik here to view.
Clik here to view.
NTCELL® Continues to Reverse the Progression of Parkinson’s Disease – One...
SYDNEY & AUCKLAND, New Zealand Over a year after treatment all four patients who took part in Living Cell Technologies Limited’s Phase I/IIa clinical study of NTCELL® for Parkinson’s disease...
View ArticleClik here to view.
Turning Back the Clock Has Never Been So Simple! TL Thread Lifting
SEOUL, South Korea As education level & social status of women get elevated, the entry of women in public affairs has also expanded, making one’s beautiful appearance as one of the biggest...
View ArticleClik here to view.
Dr. Reddy’s to Release Q3FY16 Results on Feb 9, 2016; Earnings Call Slated...
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY; NSE: DRREDDY; BSE: 500124) will announce results for the Third Quarter and 9 months ended December 31, 2015 on Tuesday, February 9, 2016 after...
View ArticleClik here to view.
Agilis Biotherapeutics and National Taiwan University Enter into Worldwide,...
CAMBRIDGE, Mass. Agilis Biotherapeutics, LLC (Agilis), a biotechnology company advancing innovative gene therapies for rare genetic diseases that affect the central nervous system (CNS), announced...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved...
View ArticleClik here to view.
Hoya Reports Third Quarter Results; Record Nine Months Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the third quarter ended December 31, 2015. During the quarter, the Group sales totaled 127,645 million yen, decreasing by...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod™...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announced today the U.S. Food and Drug Administration (US FDA) tentative approval for Zenavod™...
View ArticleClik here to view.
PENTAX Medical事業部長にジェラルド・W. ボッテロ が就任
東京 （ビジネスワイヤ） — HOYAグループPENTAX Medical事業部はこのたび、2016年2月1日付でジェラルド・W. ボッテロが医療用内視鏡の製造・販売を行うPENTAX Medical事業部長に就任したことを発表します。 HOYA株式会社 代表執行役最高経営責任者 (CEO)である鈴木 洋は、ボッテロの事業部長就任にあたり「ボッテロをPENTAX...
View Article